Vesugen Peptide is a bioregulatory tripeptide (Lys-Glu-Asp) designed to support vascular health and promote longevity by targeting the endothelial cells that line blood vessels.  Its primary health benefits include:
Improved Vascular Health: Vesugen helps maintain the structure, elasticity, and function of blood vessels, reducing the risk of atherosclerosis, hypertension, and vascular stenosis by normalizing endothelin-1 expression and enhancing endothelial repair. 
Enhanced Circulation: By promoting vasodilation through increased nitric oxide and prostaglandin I2 production, Vesugen improves blood flow, oxygen delivery, and nutrient transport throughout the body. 
Anti-Aging & Geroprotective Effects: It supports cellular longevity by upregulating sirtuin 1 (SIRT1), a protein linked to calorie restriction and slowed aging.  Research shows it may reduce biological age markers and protect against age-related vascular decline.
Neuroprotection and Brain Health: Improved cerebral microcirculation supports cognitive function, memory, and mental clarity. It may help in recovery from ischemic events like stroke and reduce risk of vascular dementia. 
Angiogenesis Support: Vesugen stimulates the formation of new blood vessels, aiding tissue regeneration and recovery from injury or ischemia. 
Reduced Inflammation and Oxidative Stress: It helps lower vascular inflammation and protects endothelial cells from damage caused by metabolic stress and aging. 
Cardiovascular Protection: May reduce the risk of heart attacks, strokes, and ischemic heart disease by maintaining clean, flexible arteries and improving vascular integrity. 
While generally well-tolerated in short-term clinical use, Vesugen is not FDA-approved and remains primarily studied in Russian research. It is typically used in cyclical protocols (10–30 days, repeated every few months) via oral capsules or sublingual drops. Always consult a healthcare provider before starting any new peptide therapy.